Staphylococcus

Pfizer continues study of Staphylococcus aureus vaccine for elective spinal fusion surgery

Pfizer Inc. announced the enrollment of the first patient in a Phase 2b clinical trial of its investigational Staphylococcus aureus multi-antigen vaccine…